This document summarizes a clinical study conducted in multiple cities in Slovakia and the Czech Republic to evaluate the effects of applying Cicatrix® cream on fresh surgical scars and wounds. The study involved 132 patients who applied the cream twice daily for 3-8 weeks. Results showed that Cicatrix® cream produced excellent or satisfactory cosmetic results without scarring in 53.97% of patients, compared to 25.00% for the placebo. The cream was found to be an effective preventative and therapeutic treatment for scars.
MedMAP finger prick blood test presentation from MaxiMedrx.comMaxiMedRx
MedMAP Blood Test is a comprehensive, multi-drug assay designed to help guide providers through the complex process of managing medications for their patients suffering from multiple chronic conditions.
From a simple fingerstick, MedMAP tests for approximately 85% of written prescriptions, marries the detected medications with the drugs on the med list, and identifies known potential drug-drug interactions. Equipped with the correct med list, providers can now develop more effective medication therapy plans and improve patient safety & adherence.
MedMAP is covered by many insurances. MaxiMed is always looking for medical sales reps with physician relationships. www.maximedrx.com
MedMAP finger prick blood test presentation from MaxiMedrx.comMaxiMedRx
MedMAP Blood Test is a comprehensive, multi-drug assay designed to help guide providers through the complex process of managing medications for their patients suffering from multiple chronic conditions.
From a simple fingerstick, MedMAP tests for approximately 85% of written prescriptions, marries the detected medications with the drugs on the med list, and identifies known potential drug-drug interactions. Equipped with the correct med list, providers can now develop more effective medication therapy plans and improve patient safety & adherence.
MedMAP is covered by many insurances. MaxiMed is always looking for medical sales reps with physician relationships. www.maximedrx.com
Presented by- Dr. Manorama Baheti, Co Authors- Dr. Vidya Patil, Dr. Kishor Patil, Dr. Dhiraj Balwir ( Disclosure: Author has no financial interest )Dr. Vasantrao Pawar Medical College
Clinical Trials: Types and Design
Experimental Study- RCT and Non RCT, Observation Study: Cohort, Case Control, Cross sectional
Clinical Trial Study Team Roles and responsibilities of Clinical Trial Personnel: Investigator, Study Coordinator, Sponsor, Contract Research Organization and its management.
Journal Club presentation in Nursing ResearchDhara Vyas
Journal presentation in Nursing Research,
Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic
Covid-19
Abstract
Introduction
Methodology
samples
Analysis
Webinar Series on Demystifying Phases in Clinical Trials & COVID-19 Updates organized by Institute for Clinical Research (ICR), NIH
Speaker: Dr Chow Ting Soo, Consultant Infectious Disease Physician, Penang General Hospital, Malaysia.
More information, please visit: https://clinupcovid.mailerpage.com/resources/w5b4h7-palliative-care-in-covid-19-malay
What Are the Different Phases of Clinical Trials?Robert Hindes MD
Well versed in clinical trials and research, particularly those targeting the treatment of hepatitis C virus infection, Robert Hindes, MD, cofounded Trek Therapeutics, PBC, where he functions as the chief medical officer. A contributor to The Lancet Infectious Diseases and other medical journals, Robert Hindes, MD, has managed different phases of clinical trials.
Adapting Clinical Trials During a Global Pandemic: Lessons LearnedClinosolIndia
The COVID-19 pandemic has had a significant impact on clinical trials worldwide, requiring rapid adaptations to ensure patient safety, data integrity, and the continuity of research efforts. Several key lessons have been learned during this challenging time:
Flexibility and Adaptability: The pandemic highlighted the importance of flexibility in clinical trial design and operations. Researchers and regulatory bodies had to quickly adapt protocols to accommodate remote visits, decentralized approaches, and virtual assessments. Being able to modify protocols and implement alternative strategies allowed trials to continue while minimizing disruptions.
Remote Monitoring and Data Collection: Remote monitoring and data collection became crucial during the pandemic to ensure patient safety and collect data without in-person visits. Technologies such as wearable devices, telemedicine platforms, and electronic patient-reported outcomes (ePROs) played a significant role in enabling remote data collection and reducing the need for site visits.
Patient-Centric Approaches: The pandemic emphasized the importance of considering patients' needs and preferences. Remote visits, home healthcare services, and decentralized trial models were implemented to reduce the burden on patients and ensure their safety. Patient engagement and education became even more critical to maintain participation and retention in trials.
Regulatory Flexibility: Regulatory agencies recognized the need for flexibility during the pandemic and implemented measures to expedite trial approvals and amendments. They provided guidance on remote monitoring, virtual visits, and other alternative approaches, allowing researchers to adapt quickly while ensuring patient safety and data integrity.
Presented by- Dr. Manorama Baheti, Co Authors- Dr. Vidya Patil, Dr. Kishor Patil, Dr. Dhiraj Balwir ( Disclosure: Author has no financial interest )Dr. Vasantrao Pawar Medical College
Clinical Trials: Types and Design
Experimental Study- RCT and Non RCT, Observation Study: Cohort, Case Control, Cross sectional
Clinical Trial Study Team Roles and responsibilities of Clinical Trial Personnel: Investigator, Study Coordinator, Sponsor, Contract Research Organization and its management.
Journal Club presentation in Nursing ResearchDhara Vyas
Journal presentation in Nursing Research,
Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic
Covid-19
Abstract
Introduction
Methodology
samples
Analysis
Webinar Series on Demystifying Phases in Clinical Trials & COVID-19 Updates organized by Institute for Clinical Research (ICR), NIH
Speaker: Dr Chow Ting Soo, Consultant Infectious Disease Physician, Penang General Hospital, Malaysia.
More information, please visit: https://clinupcovid.mailerpage.com/resources/w5b4h7-palliative-care-in-covid-19-malay
What Are the Different Phases of Clinical Trials?Robert Hindes MD
Well versed in clinical trials and research, particularly those targeting the treatment of hepatitis C virus infection, Robert Hindes, MD, cofounded Trek Therapeutics, PBC, where he functions as the chief medical officer. A contributor to The Lancet Infectious Diseases and other medical journals, Robert Hindes, MD, has managed different phases of clinical trials.
Adapting Clinical Trials During a Global Pandemic: Lessons LearnedClinosolIndia
The COVID-19 pandemic has had a significant impact on clinical trials worldwide, requiring rapid adaptations to ensure patient safety, data integrity, and the continuity of research efforts. Several key lessons have been learned during this challenging time:
Flexibility and Adaptability: The pandemic highlighted the importance of flexibility in clinical trial design and operations. Researchers and regulatory bodies had to quickly adapt protocols to accommodate remote visits, decentralized approaches, and virtual assessments. Being able to modify protocols and implement alternative strategies allowed trials to continue while minimizing disruptions.
Remote Monitoring and Data Collection: Remote monitoring and data collection became crucial during the pandemic to ensure patient safety and collect data without in-person visits. Technologies such as wearable devices, telemedicine platforms, and electronic patient-reported outcomes (ePROs) played a significant role in enabling remote data collection and reducing the need for site visits.
Patient-Centric Approaches: The pandemic emphasized the importance of considering patients' needs and preferences. Remote visits, home healthcare services, and decentralized trial models were implemented to reduce the burden on patients and ensure their safety. Patient engagement and education became even more critical to maintain participation and retention in trials.
Regulatory Flexibility: Regulatory agencies recognized the need for flexibility during the pandemic and implemented measures to expedite trial approvals and amendments. They provided guidance on remote monitoring, virtual visits, and other alternative approaches, allowing researchers to adapt quickly while ensuring patient safety and data integrity.
LETS KNOW ABOUT - SURGICAL SITE INFECTION(SSI).
Infections of the incision or organ or space, that occur after surgery.
60% of SSIs -preventable with evidence-based guidelines.
MC and costliest hospital-acquired infections, 20% of all hospital infections.
CLAClassified based on the depth and tissue layers .
Superficial incisional SSI
Primary or secondary.
Deep incisional SSI
Primary or secondary.
Organ/space SSI
SUPERFICIAL INCISIONAL SSI
Infection occurs within 30 days after the operative procedure and involves only skin and subcutaneous tissue of the incision and had at least one of the following:
a. Purulent drainage from the superficial incision.
b. Organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial incision.
c. At least one of the following signs or symptoms of infection: pain or tenderness, localized swelling, redness, or heat, and superficial incision is deliberately opened by surgeon and is culture positive or not cultured. A culture-negative finding does not meet this criterion.
d. Diagnosis of superficial incisional SSI by the surgeon or attending physician
DEEP INCISIONAL SSI
Infection occurs within 30 days after the operative procedure if no implant is left in place or within 3 months if implant is in place and the infection appears to be related to the operative procedure and involves deep soft tissues (e.g., fascial and muscle layers) of the incision and patient has at least one of the following:
a. Purulent drainage from the deep incision but not from organ/space component of the surgical site.
b. Deep incision spontaneously dehisces or is deliberately opened by a surgeon and is culture-positive or not cultured when the patient has at least one of the following signs or symptoms: fever (>38°C) or localized pain or tenderness. A culture-negative finding does not meet this criterion.
c. An abscess or other evidence of infection involving the deep incision is found on direct examination, during reoperation, or by histopathologic or radiologic examination.
d. Diagnosis of a deep incisional SSI by a surgeon or attending physician.Wound that has both superficial and deep incisional infection is classified as DIS
ORGAN SPACE SSI
Infection occurs within 30 days after the operative procedure if no implant is left in place or within 3 months if implant is in place and the infection appears to be related to the operative procedure and infection involves any part of the body, excluding the skin incision, fascia, or muscle layers, that is opened or manipulated during the operative procedure and patient has at least one of the following:
a. Purulent drainage from a drain that is placed through a stab wound into the organ/space.
b. Organisms isolated from an aseptically obtained culture of fluid or tissue in the organ/space.
c. An abscess or other evidence of infection involving the organ/space that is found on direct examination, during reoperation, or by histopathologic or radiologic examination.
Tyu
Webinar Series on Demystifying Phases in Clinical Trials & COVID-19 Updates organized by Institute for Clinical Research (ICR), NIH
Speaker: Dato Dr Chang Kian Meng, Haematologist from Sunway Medical Centre
More information, please visit: https://clinupcovid.mailerpage.com/resources/p9f2i7-introduction-to-phase-2-3-trial-s
Improving Surgical Safety and Patient OutcomesC Daniel Smith
Keynote talk delivered at New Jersey Hospital Association Seminary on Improving Surgical Safety & Patient Outcomes held on September 25, 2013 at their Conference Center in Princeton New Jersey. Over physicians, administrators, nurses and perioperative services providers in attendance.
SHARE Presentation: Maximizing Treatment Options -- What to Know When Conside...bkling
Current and former clinical trial participants discuss decision-making from a patient's perspective. What factors should you consider when choosing a clinical trial? What are the potential benefits of participating? What misconceptions might discourage people from seeking clinical trials? When is it best not to participate? Panelists include women living with metastatic breast and ovarian cancers.
Randomized Control Trials
Enigma of Blinding Unraveled
Introduction
RCT
Steps in a RCT
Allocation Concealment
Bias in RCT
Phases in RCT
Types of RCT
Study Designs of RCT
Blinding
Methods of Blinding in different trials
Assessment of Blinding
Un-blinding
Current Scenario of Blinding
CONSORT
Conclusion
References
Effect of hydrocortisone on development of shock amongDr fakhir Raza
effects of hydrocortisone on development of shock among patients with severe sepsis the HYPRESS Randomized Clinical Trial American Medical Association caring for the critically ill patients Surviving sepsis campaign, to determine weather hydrocortisone therapy in patients with severe sepsis prevents the development of septic shock
Verolax es un medicamento laxante de uso rectal para la administración en niños entre 2 y 12 años. Por su principio activo glicerol, está indicado para el alivio local sintomático del estreñimiento transitorio y ocasional. Consulte su prospecto.
Artific 3,20 mg/ml colirio en solución 10 ml.
Artific es un colirio medicamento que pertenece al grupo de lágrimas artificiales. Indicado para la sequedad ocular. Artific colirio 10ml.
Verolax adultos solución rectal 6 unidosis
Verolax adulto es un medicamento laxante de uso rectal para la administración mayores de 12 años. Por su principio activo glicerol, está indicado para el alivio local sintomático del estreñimiento transitorio y ocasional. Consulte su prospecto.
Artific 3,20 mg/ml colirio en solución 30 unidosis
Artific es un colirio medicamento que pertenece al grupo de lágrimas artificiales. Indicado para la sequedad ocular. Artific colirio monodosis.
Algipatch es un medicamento del grupo de los antiinflamatorios no esteroides. Indicado para tratamiento del dolor agudo asociado al esguinces, torceduras o contusiones en brazos y piernas, producidos por lesiones con objetos contundentes. Sólo para uso cutáneo.
Sekisan es un medicamento con Cloperastina en su principio activo. Es un antitusivo,
indicado para inhibir la tos. Tos improductivas, irritativas, tos tos nerviosa para adultos y
niños a partir de 2 años.
Prospecto Rino Ebastel 10mg 120mg cápsulas duras liberación modificadaFarmacia Internacional
RinoEbastel
es una medicamento indicado para el alivio de los síntomas nasales y oculares
asociados a la rinitis alérgica estacional. Rino Ebastel está recomendado para adultos y
adolescentes a partir de 12 años.
Calmatel es un medicamento que pertenece al grupo de medicamentos llamados antiinflamatorios no
esteroideos (AINEs). Indicado para mayores de 12 años en casos de inflamación leves producidas por
contusiones, golpes, distensiones, tortícolis. Consulte todo su prospecto
Calmatel es un medicamento para el alivio local del dolor y en casos de inflamación leves
producidas por contusiones, golpes, distensiones, tortícolis. Consulte todo su prospecto.
Para mayores de 12 años.
Almax es un medicamentos que pertenece a un grupo de medicamentos denominados antiácidos, indicado para el alivio y tratamiento sintomático de la acidez y ardor de estómago en adultos y mayores de 12 años. También disponible en sobres.
Evacuol es un medicamento laxante. Su acción produce por estímulo directo del intestino grueso. Evacuol en gotas está indicado para adultos, para alivio de síntomas del estreñimiento ocasional.Por favor leer todo el prospecto antes de comprar este medicamento.
Prospecto Calmatel spray 33,28 mg-ml para pulverización cutánea 100mlFarmacia Internacional
Calmatel Spray es una solución para pulverización cutánea antiinflamatorios indicado para
mayores de 12 años en caso de inflamación leves y ocasionales producidos por pequeñas
contusiones, golpes, distensiones
Blastoestimulina 2% Polvo cutáneo es un medicamento de acción cicatrizante, indicado
para heridas, úlceras, llagas, escaras y quemaduras de la piel. también para postoperatorios
en heridas quirúrgicas. Consulte todo el prospecto descargable.
Almax Forte en sobres es medicamento antiácidos, indicado para el alivio sintomático de la
acidez del estómago en adultos. Consulte el prospecto de Almax Forte antes de comprarlo.
Actithiol Mucolítico Antihistamínico Solución oral. Este medicamento se utiliza para el alivio
sintomático de molestias de componente respiratorio. También ayuda en el alivio y
fluidificación y auxiliar en eliminación de mocos. Lea todo el prospecto antes de comprar.
Laboratorios Alter presenta la nueva fórmula del gel Nani Predental, un anestésico local de uso tópico que alivia las molestias originadas por la aparición de los primeros dientes. La consecuencia de la salida de los primeros dientes es la perforación...
Couldina con paracetamol está indicado para el alivio de los síntomas de los catarros y gripes que cursan con fiebre o dolor leve o moderado, congestión y secreción nasal. Adultos y adolescentes a partir de 15 años.
Couldespir es una indicada para la descongestión nasal, para alivio sintomático de cogestión consecuente de resfriados, sinusitis, rinitis. Consulte nuestro prospecto antes de administrar Couldespir
El medicamento Couldina en comprimidos efervescentes, es una asociación de ácido acetilsalicílico, clorfenamina y fenilefrina. Indicado para uso adulto, actúa sobre el dolor moderado y la fiebre, Leer atentamente las instrucciones de administración de este medicamento en su prospecto (para que sirve, indicaciones)
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
1. CLINICAL STUDY
International multicentre study to verify the effects of applying
Cicatrix® cream CATALYSIS, S. L. Madrid
in patients with fresh surgical scars or traumatic wounds
Participating countries and cities: 1. Slovakia Svidník and Žilina
2. Czech Republic Prague and Brno
Participating Doctors: Svidník I (Dr. Hana Zelenková, Ph.D.)
Svidník II (Dr. Júlia Stracenská)
Žilina (Dr. Alena Nejdková
Brno (Dr. Jarmila Rulcová, Ph.D.)
Prague (Dr. Jiřina Cabalová)
Brno (Dr. Zuzana Vykutilová)
Svidník
2008
2. CLINICAL STUDY
International multicentre study to verify the effects of applying
Cicatrix® cream CATALYSIS, S. L. Madrid
in patients with fresh surgical scars or traumatic wounds
Prospective randomised controlled open type IV trial with post-registration monitoring
and continuous inclusion of patients into the trial according to set criteria aimed to the
following objectives:
• to prove the efficacy and tolerability of applying Cicatrix®
cream, a product of
CATALYSIS S.L. Madrid, in patients with fresh surgical scars or traumatic wounds and
to assess differences in tolerability and the final healing acceleration effect, and the effect
on keloid and hypertrophic scars formation in individual patients.
• to verify the validity of results in comparison with placebo in selected groups of patients
in randomly selected centres.
Number of Patients: 132 (22 men and 104 women)
Number of applications: 2 times a day with a system of massage
movements
Application duration: min. 21 days (3 weeks), max 90 days (3 months)
Application information: given by the therapist both orally and in writing
Documentation: Working Protocol, tables
Basic laboratory screening: performed in every patient
Photodocumentation: pictures taken 2 – 3 times in every patient
Recommended daily hygiene: non irritating preparations with no influence on the
therapy process
3. CLINICAL STUDY
Inclusion criteria
• Fresh surgical scars or traumatic wounds (burns, cuts)
• Male or female gender, Caucasian
• Inpatient or outpatient status
• Ag : 10 – 82 years
• Voluntary participation in the trial
• Written patient consent form confirmation
• One-time participation in the trial
Exclusion criteria
Specific exclusion criteria
• Bleeding wound or scar
• Open wound
• Known allergies to the tested preparation
• Disease focus infection manifestations
(superinfection requiring therapy)
• Immunosuppressive therapy
• Cancer
• Malignancies
• Employment of other drug/s and /or preparation/s in therapy
General exclusion criteria
• Alcohol and drug abuse
• Painkiller abuse
• Participation in another clinical trial within the past 30 days
• Simultaneous participation in any other clinical trial
• Other reasons excluding the patient from the trial
• Restricted ability of the patient to follow therapy instructions
• Other physical or mental disorders disturbing the trial plan
• Possible consent withdrawal, presumed patient unreliability
4. CLINICAL STUDY
CONCLUSIONS
The results of the assessment of the therapeutic effect of Cicatrix®
cream, Catalysis S. L. Madrid versus placebo performed by the therapists in a
group of 126 patients speak clearly in favour of Cicatrix®
cream as follows:
• 53.97% patients on Cicatrix® cream vs. 25.00% patients on placebo
excellent cosmetic and aesthetic effect, accelerated healing without visible scar
formation.
• 30.16% patients on Cicatrix® cream vs. 33.33% patient on placebo
satisfactory aesthetic and cosmetic effect, slight erythema and infiltration around the scar
on the day of trial completion.
• 8.73% patients on Cicatrix® cream vs. 41.67% patients on placebo
insignificant improvement, erythema, infiltration, mild oedema, itching.
• 7.14% patients on Cicatrix® cream vs. 0 % patients on placebo
keloid formation, dissatisfactory condition.
• The most significant effects were observed in patients with small extent scars on the
face, where the skin is not as much exposed to pressure or stretching and where the right
system of care is connected with minimum risk of complications.
• Great effects were achieved in patients with burns, where Cicatrix® cream was applied
starting on day 5 or day 7 when the affected areas were no longer secerning. These healed
with no signs of scarring.
• Similarly great effects were obtained in elderly patients, in which a catamnestic study
performed 4 months after trial completion has proven that there are no scars present in
the operated area.
• Surprisingly good effects were observed in patients after blepharoplasty and in patients
with extensive scars after breast reduction or leg surgery.
• Based on the results obtained within the trial, therapy with Cicatrix®
cream, a
product of Catalysis S. L. Madrid, is a very elegant and highly effective preventive
and therapeutic modality. In order to potentiate the final effects, it is necessary to
apply the preparation using a system of special massage movements (to accelerate
the deterioration of scar fibres and start the formation of capillaries.